At the 2026 ATS International Conference in Cincinnati, researchers unveiled findings that challenge how we think about treating children with chronic lung disease: a pulmonary rehabilitation program improved kids' ability to exercise, boosted their strength, and enhanced their quality of life—even when the numbers on their lung function tests stayed exactly the same.
This matters because for decades, doctors have relied on spirometry, a standard breathing test, to measure whether respiratory treatments are working. But Tauras Vucianis, a third-year medical student at the University of Cincinnati College of Medicine, and his team discovered something more nuanced. The children in their study felt measurably better and could do more physically, even if their spirometry results didn't budge. "Meaningful clinical improvement extends beyond spirometry," Vucianis noted, suggesting that physicians may have been missing real progress by focusing solely on test scores.
The research tracked 51 children who enrolled in a pediatric pulmonary rehabilitation program and completed at least five sessions. Participants showed significant improvements in exercise capacity and reported considerable gains in quality of life. Patient and caregiver satisfaction was very high, indicating the program worked not just in theory but in practice—families actually found it acceptable and feasible to participate.
The timing of this research is significant. Pulmonary rehabilitation for adults with chronic respiratory diseases like COPD is routine and well-established. Yet pediatric programs remain rare, partly because there's no standardized playbook. Children of different ages need different approaches; a seven-year-old requires a different exercise strategy than a teenager. Programs must be tailored to each child's age, behavior, and what they're physically capable of doing. Creating individualized pathways takes more work than one-size-fits-all protocols.
What makes Vucianis's findings particularly hopeful is the durability of the intervention. The program wasn't just about supervised exercise sessions—it aimed to build children's confidence in managing their own disease and to inspire them to keep moving once they left the facility. "We are always thrilled to hear that our former participants are continuing to implement their own exercise programs long after their PR sessions have ended," Vucianis said. In other words, kids internalized the lessons and kept going.
The implications are broad. For children living with chronic respiratory conditions—whether asthma, cystic fibrosis, pulmonary hypertension, or other long-term lung diseases—this work suggests that rehabilitation isn't a dead end or a consolation prize when lung function can't be fully restored. It's a legitimate pathway to a more functional, confident, active life. It gives families something concrete to pursue beyond medication alone.
The research team plans to continue investigating how pediatric pulmonary rehabilitation stacks up over longer periods, when the best time to start such programs might be, and what other outcomes improve beyond exercise capacity. As more hospitals and clinics recognize the value of these programs, more children could gain access to the tools and support needed to breathe easier and live fuller lives—measured not just by what spirometry says, but by what kids can actually do.